End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.52 CNY | +1.79% | -4.91% | -36.56% |
Strengths
- With a P/E ratio at 11.55 for the current year and 7.22 for next year, earnings multiples are highly attractive compared with competitors.
- With regards to fundamentals, the enterprise value to sales ratio is at 0.81 for the current period. Therefore, the company is undervalued.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
Ratings chart - Surperformance
Sector: Food Processing
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-36.56% | 603M | - | ||
-1.96% | 287B | A- | ||
-6.52% | 90.96B | C+ | ||
-9.34% | 41.76B | C+ | ||
+1.12% | 41.74B | B- | ||
+2.83% | 39.65B | B- | ||
+2.03% | 38.08B | B- | ||
-14.35% | 30.29B | B- | ||
-4.23% | 28.91B | A | ||
+7.56% | 24.27B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 300138 Stock
- Ratings ChenGuang Biotech Group Co., Ltd.